The outlook for new molecular entities

被引：0

|

作者：

机构：

来源：

Pharm. Technol. | 2006年 / 10卷 / 64-70期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[41] New molecular entities - Torisel - Temsirolimus
Wyeth
FORMULARY, 2007, 42 (07) : 424 - 424
[42] New molecular entities - Spiriva HandiHaler
不详
FORMULARY, 2004, 39 (03) : 137 - 137
[43] FDA approval of new molecular entities
Kostel, K
SCIENTIST, 2004, 18 (12): : 45 - 45
[44] New molecular entities - Clarinex - (dutasteride) - Elidel
不详
FORMULARY, 2002, 37 (02) : 61 - 63
[45] BDDCS Class Prediction for New Molecular Entities
Broccatelli, Fabio
Cruciani, Gabriele
Benet, Leslie Z.
Oprea, Tudor I.
MOLECULAR PHARMACEUTICS, 2012, 9 (03) : 570 - 580
[46] New molecular entities/new biologics - Fuzeon - Enfuvirtide for injection
不详
FORMULARY, 2003, 38 (04) : 182 - +
[47] 2017 in review: FDA approvals of new molecular entities
Kinch, Michael S.
Griesenauer, Rebekah H.
DRUG DISCOVERY TODAY, 2018, 23 (08) : 1469 - 1473
[48] New molecular entities - Noxafil - Posaconazole oral suspension
不详
FORMULARY, 2006, 41 (10) : 488 - 488
[49] New molecular entities - Neupro - Rotigotine transdermal system
Schwarz
FORMULARY, 2007, 42 (07) : 424 - 425
[50] Antibiotic Drug Discovery: New Targets and Molecular Entities
Tondi, Donatella
CHEMMEDCHEM, 2018, 13 (17) : 1848 - 1849

← 1 2 3 4 5 →